Vol. 11, Special Issue 7 (2022)
Therapeutic efficacy of cefquinome in management of subclinical mastitis in buffaloes
Author(s):
Dinesh Kumar Yadav, Jitendra Pratap Singh, Satyavrat Singh, Rakesh Kumar Gupta, Naveen Kumar Singh, SK Maurya and RK Joshi
Abstract:
Subclinical mastitis is an inflammatory reaction of udder tissue without apparent signs mainly caused by microorganisms characterized by high somatic cell count. The present study was conducted in 120 buffaloes affected with subclinical mastitis to assess the therapeutic efficacy of cefquinome. Buffaloes with subclinical mastitis were divided into four groups (30 animals in each group) and were subjected to 4 different treatment protocols and recovery status was assessed based on CMT score and Somatic cell count. Animals in group I and II were administered with injection Cefquinome and injection Enrofloxacin respectively. In Group III and IV herbal spray were administered along with antibiotics in group I and II. Highest recovery was recorded in group III (96.67%) and group IV (96.67%) followed by group II (93.33%), group I (90%). A significant decline in CMT score and somatic cell count was also recorded.
How to cite this article:
Dinesh Kumar Yadav, Jitendra Pratap Singh, Satyavrat Singh, Rakesh Kumar Gupta, Naveen Kumar Singh, SK Maurya and RK Joshi. Therapeutic efficacy of cefquinome in management of subclinical mastitis in buffaloes. The Pharma Innovation Journal. 2022; 11(7S): 3516-3519.